v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (11,262,000) $ (7,902,000)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization 1,278,000 1,058,000
Issuance of common stock for bonus 870,000
Stock-based payments for professional services rendered 190,000
Stock-based payments to employees and directors 1,440,000 4,000
Loss on equity method investment 367,000 5,000
Unrealized loss on investments 818,000 303,000
Change in ROU assets 315,000 330,000
(Loss) gain on allowance for obsolescence of inventory 2,000 (21,000)
Provision for loan loss recoveries 235,000
Impairment of intangible asset 600,000
Amortization of debt discount 32,000
Loss on sale of real estate 250,000
Decrease (increase) in assets:    
Accounts receivable 968,000 380,000
Inventory 18,000 (80,000)
Assets held for sale (38,000)
Prepaid expenses and other current assets 182,000 241,000
Investments in trading securities 1,984,000 (884,000)
Other assets 6,000 (802,000)
Increase (decrease) in liabilities:    
Accounts payable 590,000 (287,000)
Accrued expenses 334,000 (26,000)
ROU liabilities (313,000) (313,000)
Accrued interest on notes payable 1,208,000 1,884,000
Other liabilities 48,000 3,549,000
Net cash (used) provided by operating activities (1,985,000) (454,000)
Cash flows from investing activities:    
Purchase of property, plant and equipment (214,000) (144,000)
Purchase of convertible bond - related party (2,450,000)
Sale of real estate 9,500,000
Sale of investment, related party 1,500,000
Issuance of new notes receivable, net origination fees (50,000)  
Payments received on notes receivable 7,000 163,000
Net cash (used) provided by investing activities (2,707,000) 11,019,000
Cash flows from financing activities:    
Payments of long-term debt (628,000) (9,443,000)
Borrowings of long-term debt, net 73,000 109,000
Payment on margin loans (1,152,000) (3,178,000)
Borrowings of convertible note payable - related party 3,450,000
Issuances of common stock, net of issuance costs 703,000
Net cash provided (used) by financing activities 2,446,000 (12,512,000)
Net decrease in cash (2,246,000) (1,947,000)
Cash, cash equivalents and restricted cash at beginning of period 6,314,000 11,431,000
Cash and cash equivalents at end of period $ 4,068,000 $ 9,484,000